DOMH vs HIVE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 02, 2026

DOMH

43.2
AI Score
VS
HIVE Wins

HIVE

56.4
AI Score

Investment Advisor Scores

DOMH

43score
Recommendation
HOLD

HIVE

56score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric DOMH HIVE Winner
Revenue 35.80M 225.97M HIVE
Net Income -57.36M -72.11M DOMH
Net Margin -160.2% -31.9% HIVE
ROE -181.5% -12.9% HIVE
ROA -67.2% -11.6% HIVE
Total Assets 85.32M 624.00M HIVE
Cash 27.48M 14.07M DOMH

Relative Price Performance (Last 90 Days)

DOMH 1M: -16.7% · 3M: -11.8% HIVE 1M: -18.2% · 3M: +17.4%

Current Technical Phase

DOMH

Markdown
Sell / avoid

Price below a falling SMA50 (slope -6.6%), weak momentum, RSI 42

RSI (14): 41.8 · Price: $2.54

HIVE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 42

RSI (14): 42.0 · Price: $2.83

Fundamentals Snapshot

Metric DOMH HIVE
Market Cap
Forward P/E 0.0 -5.5
Trailing P/E
Revenue (TTM)
Revenue Growth 3.9% 1.3%
Gross Margin 1.0% 0.4%
Operating Margin -1.1% -0.8%
EPS -1.72 -0.78
Dividend Yield 0.00%

Frequently Asked Questions

Based on our detailed analysis, HIVE is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.